Document Detail


How do we know when peanut and tree nut allergy have resolved, and how do we keep it resolved?
MedLine Citation:
PMID:  20645999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the last two decades, the prevalence of peanut and tree nut allergy has increased throughout the western world. Adverse reactions to these foods account for over 50% of all deaths resulting from food-related anaphylaxis. Until recently, evidence suggested that all peanut and tree nut allergy were permanent. It is now known that about 20% and 10%, respectively, of young patients outgrow peanut and tree nut allergies. Achieving tolerance is associated with increasing circulating T regulatory cells and reduced production of allergen-specific IgE. Reliable predictors of resolution are not yet available. A direct correlation between skin test weal size and allergen-specific IgE, at the time of diagnosis and likelihood of resolution, has been reported. Resolution of peanut or tree nut allergy cannot be determined conclusively by either allergen-specific IgE analysis or by skin prick testing. Oral food challenge is the gold standard for determining resolution of food allergy. Food challenges should only be undertaken in a clinical setting fully equipped to deal with a potential severe adverse reaction. Approximately 8% of patients who outgrow peanut allergy may suffer a recurrence, but recurrent tree nut allergy has not been reported to date. Infrequent ingestion of peanut may be related to the re-emergence of allergy. Induction of tolerance through oral immunotherapy or sublingual immunotherapy is now being actively studied, but remains experimental. Studies have reported short-term desensitization to peanut, but ongoing follow-up will determine whether tolerance is achieved long term.
Authors:
A M Byrne; J Malka-Rais; A W Burks; D M Fleischer
Related Documents :
17123549 - Do tiny males grow up? sperm competition and optimal resource allocation schedule of dw...
6494279 - Feeding behavior responses of zucker rats to naloxone.
10958809 - Partial sequence and expression of the gene for and activity of the sodium glucose tran...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-20
Journal Detail:
Title:  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology     Volume:  40     ISSN:  1365-2222     ISO Abbreviation:  Clin. Exp. Allergy     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-12     Completed Date:  2011-01-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8906443     Medline TA:  Clin Exp Allergy     Country:  England    
Other Details:
Languages:  eng     Pagination:  1303-11     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Division of Pediatric Allergy and Immunology, National Jewish Health, Denver, CO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Allergens / administration & dosage
Desensitization, Immunologic
Humans
Immune Tolerance
Nut Hypersensitivity / diagnosis*,  immunology*
Peanut Hypersensitivity / diagnosis*,  immunology*,  therapy
Chemical
Reg. No./Substance:
0/Allergens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preventing obesity at weaning: parental views about the EMPOWER programme.
Next Document:  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.